SOOIL Diabecare RS/AnyDana-i/AnyDana-A up to 2.x Bluetooth LE privileges management
|CVSS Meta Temp Score|
CVSS is a standardized scoring system to determine possibilities of attacks. The Temp Score considers temporal factors like disclosure, exploit and countermeasures. The unique Meta Score calculates the average score of different sources to provide a normalized scoring system.
|Current Exploit Price (≈)|
Our analysts are monitoring exploit markets and are in contact with vulnerability brokers. The range indicates the observed or calculated exploit price to be seen on exploit markets. A good indicator to understand the monetary effort required for and the popularity of an attack.
|CTI Interest Score|
Our Cyber Threat Intelligence team is monitoring different web sites, mailing lists, exploit markets and social media networks. The CTI Interest Score identifies the interest of attackers and the security community for this specific vulnerability in real-time. A high score indicates an elevated risk to be targeted for this vulnerability.
A vulnerability, which was classified as problematic, has been found in SOOIL Diabecare RS, AnyDana-i and AnyDana-A up to 2.x. This issue affects an unknown code block of the component Bluetooth LE Handler. The manipulation with an unknown input leads to a privilege escalation vulnerability. Using CWE to declare the problem leads to CWE-269. Impacted is confidentiality. The summary by CVE is:
In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, a client-side control vulnerability in the insulin pump and its AnyDana-i and AnyDana-A mobile applications allows physically proximate attackers to bypass checks for default PINs via Bluetooth Low Energy.
The weakness was released 01/20/2021 as icsma-21-012-01. It is possible to read the advisory at us-cert.cisa.gov. The identification of this vulnerability is CVE-2020-27268 since 10/19/2020. The exploitation is known to be easy. Access to the local network is required for this attack. No form of authentication is needed for a successful exploitation. The technical details are unknown and an exploit is not publicly available.
Upgrading to version 3.0 eliminates this vulnerability.
CVSSv3VulDB Meta Base Score: 5.4
VulDB Meta Temp Score: 5.1
VulDB Base Score: 4.3
VulDB Temp Score: 4.1
VulDB Vector: 🔒
VulDB Reliability: 🔍
NVD Base Score: 6.5
NVD Vector: 🔒
VulDB Base Score: 🔒
VulDB Temp Score: 🔒
VulDB Reliability: 🔍
NVD Base Score: 🔒
ExploitingClass: Privilege escalation
Status: Not defined
Price Prediction: 🔍
Current Price Estimation: 🔒
Threat IntelligenceThreat: 🔍
0-Day Time: 🔒
Upgrade: Diabecare RS/AnyDana-i/AnyDana-A 3.0
Timeline10/19/2020 CVE assigned
01/20/2021 +93 days Advisory disclosed
01/20/2021 +0 days VulDB entry created
02/15/2021 +26 days VulDB last update
CVE: CVE-2020-27268 (🔒)
EntryCreated: 01/20/2021 08:18 AM
Updated: 02/15/2021 03:51 PM
Changes: (20) vulnerability_cwe vulnerability_cvss3_nvd_av vulnerability_cvss3_nvd_ac vulnerability_cvss3_nvd_pr vulnerability_cvss3_nvd_ui vulnerability_cvss3_nvd_s vulnerability_cvss3_nvd_c vulnerability_cvss3_nvd_i vulnerability_cvss3_nvd_a vulnerability_cvss2_nvd_av vulnerability_cvss2_nvd_ac vulnerability_cvss2_nvd_au vulnerability_cvss2_nvd_ci vulnerability_cvss2_nvd_ii vulnerability_cvss2_nvd_ai vulnerability_cvss3_meta_basescore vulnerability_cvss3_meta_tempscore exploit_price_0day vulnerability_cvss2_nvd_basescore vulnerability_cvss3_nvd_basescore
Might our Artificial Intelligence support you?
Check our Alexa App!